Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml ; volume:6 ; number:1 ; day:5 ; month:11 ; year:2011 ; pages:1-8 ; date:12.2011
Radiation oncology ; 6, Heft 1 (5.11.2011), 1-8, 12.2011
- Creator
-
Umezawa, Rei
- Contributor
-
Ariga, Hisanori
Ogawa, Yoshihiro
Jingu, Keiichi
Matsushita, Haruo
Takeda, Ken
Fujimoto, Keisuke
Sakayauchi, Toru
Sugawara, Toshiyuki
Kubozono, Masaki
Narazaki, Kakutaro
Shimizu, Eiji
Takai, Yoshihiro
Yamada, Shogo
SpringerLink (Online service)
- DOI
-
10.1186/1748-717X-6-150
- URN
-
urn:nbn:de:1111-2016072614433
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Umezawa, Rei
- Ariga, Hisanori
- Ogawa, Yoshihiro
- Jingu, Keiichi
- Matsushita, Haruo
- Takeda, Ken
- Fujimoto, Keisuke
- Sakayauchi, Toru
- Sugawara, Toshiyuki
- Kubozono, Masaki
- Narazaki, Kakutaro
- Shimizu, Eiji
- Takai, Yoshihiro
- Yamada, Shogo
- SpringerLink (Online service)
Other Objects (12)
Biological Half-Life of Prostate-Specific Antigen after Radical Prostatectomy
Introduction of salvage prostatectomy in Denmark: the initial experience
Elimination of Serum Free and Total Prostate-Specific Antigen after Radical Retropubic Prostatectomy
Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
Impact of persistent PSA after salvage radical prostatectomy: a multicenter study
Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial?
A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy
The prognosis benefits of adjuvant versus salvage radiotherapy for patients after radical prostatectomy with adverse pathological features: a systematic review and meta-analysis
Triggers and oncologic outcome of salvage radical prostatectomy, salvage radiotherapy and active surveillance after focal therapy of prostate cancer
Influence of tumor burden on serum prostate-specific antigen in prostate cancer patients undergoing radical prostatectomy
The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy
Salvage robot-assisted radical prostatectomy with pelvic lymph node dissection after cryotherapy failure
Biological Half-Life of Prostate-Specific Antigen after Radical Prostatectomy
Introduction of salvage prostatectomy in Denmark: the initial experience
Elimination of Serum Free and Total Prostate-Specific Antigen after Radical Retropubic Prostatectomy
Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
Impact of persistent PSA after salvage radical prostatectomy: a multicenter study
Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial?
A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy
The prognosis benefits of adjuvant versus salvage radiotherapy for patients after radical prostatectomy with adverse pathological features: a systematic review and meta-analysis
Triggers and oncologic outcome of salvage radical prostatectomy, salvage radiotherapy and active surveillance after focal therapy of prostate cancer
Influence of tumor burden on serum prostate-specific antigen in prostate cancer patients undergoing radical prostatectomy
The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy
Salvage robot-assisted radical prostatectomy with pelvic lymph node dissection after cryotherapy failure
Biological Half-Life of Prostate-Specific Antigen after Radical Prostatectomy
Introduction of salvage prostatectomy in Denmark: the initial experience
Elimination of Serum Free and Total Prostate-Specific Antigen after Radical Retropubic Prostatectomy
Study of prostate-specific antigen levels during salvage radiotherapy after prostate cancer surgery
Impact of persistent PSA after salvage radical prostatectomy: a multicenter study
Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial?
A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomy
The prognosis benefits of adjuvant versus salvage radiotherapy for patients after radical prostatectomy with adverse pathological features: a systematic review and meta-analysis
Triggers and oncologic outcome of salvage radical prostatectomy, salvage radiotherapy and active surveillance after focal therapy of prostate cancer
Influence of tumor burden on serum prostate-specific antigen in prostate cancer patients undergoing radical prostatectomy
The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy